Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Stematix, a regenerative medicine provider positioned to accelerate safe and effective global use of stem cell therapies, has entered into a ten-year exclusive agreement with Laboratorios Bago (Buenos Aires, Argentina), an Argentine medical products company.
Subscribe to our email newsletter
As per the agreement, Laboratorios Bago will distribute a variety of Stematix orthopedic and cellular products for use in regenerative and related medical treatments. The terms of the contract were not disclosed, but the contract also provides the option of additional forms of joint collaboration in clinical trials and treatments.
Stematix is a regenerative medicine delivery company, whose goal is to make regenerative medicine products and treatments available to patients as soon as possible, at reasonable cost and to international medical standards.
Laboratorios Bago is one of the major Argentine medical products organizations with a presence in several Latin American countries. The Bago Group comprises different companies focused on health care and on improving life quality, as well as providing high tech services in strategic areas.